<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>: iStockAnalyst.com  Symbols Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>Custom RSS Feed</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Sun, 06 Dec 2009 08:23:37 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Invest In HealthCare!</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3675989</guid>
      <description><![CDATA[In 3 of the past 4 market rebounds since 1982, equity gains slowed to a single digit pace in the 2nd year, after the initial rally.&#160;Now dividend stocks have extra appeal because they offer a tempting alternative to CDs which pay virtually no interest at all, and long term bonds which pay a little bit more but leave you at the mercy of inflation. &#160;
 &#160;
 Established value companies in stable industries have usually proven a better long-term investment.&#160;Before S&amp;P cut Pfizer (PFE) ratings to 'AA' from 'AAA' on Oct 16, 2009, there were 5 companies with AAA credit ratings: Automated Data Processing (ADP), Johnson &amp; Johnson (JNJ), ExxonMobil (XOM) and Microsoft (MSFT).&#160;In other words, 2 out of 5 were healthcare companies.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3675989>[More...]</a>]]></description>
      <pubDate>Tue, 01 Dec 2009 16:52:08 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AAA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BMY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CBPO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ELI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NBI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NNYP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOVO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UNH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3675989</link>
    </item>
    <item>
      <title>Baxter (BAX): Bank On Blood Products</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3658061</guid>
      <description><![CDATA[&quot;Baxter International (NYSE: BAX)&#160;benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates,&quot; says Richard Moroney.

In&#160;Dow Theory Forecasts, he explains, &quot;The ?rst company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical products since 1931.&quot; Here's his bullish<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3658061>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 16:47:16 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3658061</link>
    </item>
    <item>
      <title>9 Dividend Stocks Sending More Cash To Shareholders</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3633531</guid>
      <description><![CDATA[Option implied volatility (IV) on the video game software company Electronic Arts (NYSE:ERTS) rose slightly to 49% on Monday on the news that the company was buying a London-based social network game company called Playfish. Gosh, IV fell back to 40%. Implied volatility is widely believed to be informationally superior to historical volatility, because it is the &quot;market's&quot; forecast of future volatility. Higher the volatility higher is the chance of an upside or a downside on a stock and its option.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3633531>[More...]</a>]]></description>
      <pubDate>Fri, 13 Nov 2009 14:54:28 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ERTS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPAN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TNC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYNN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3633531</link>
    </item>
    <item>
      <title>Where Are The Original Dividend Aristocrats Now?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3627449</guid>
      <description><![CDATA[The Dividend Aristocrats index measures the performance of S&amp;P 500 index members that have followed a policy of consistently increasing dividends every year for at least 25 consecutive years.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3627449>[More...]</a>]]></description>
      <pubDate>Wed, 11 Nov 2009 18:56:14 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DOV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FPL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IFF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IXX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">K</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LDG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MXM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TMK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TNT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3627449</link>
    </item>
    <item>
      <title>25 Option Write Ideas For October Expiration Friday</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3556979</guid>
      <description><![CDATA[In a previous OptionMaestro.com post, I outlined 25 stocks which I wouldn't mind going long at these levels. I wrote about getting long the stocks by using the buy-write option strategy. This is an updated post to that one, adjusting the strikes and prices accordingly for options expiration today.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3556979>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 13:49:27 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AAPL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AONE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIDU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BRCD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BWLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DOW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FSLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PALM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RMBS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STEC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TXT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WLT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3556979</link>
    </item>
    <item>
      <title>Wall Street Ends Higher On Oil, Microsoft (NASDAQ: MSFT) Rallies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3555320</guid>
      <description><![CDATA[US stocks finished up on Thursday as a rally in energy stocks offset a decline in bank shares.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3555320>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 21:54:28 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">C</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IBM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MSFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XLNX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3555320</link>
    </item>
    <item>
      <title>5 Smart Management Decisions</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553730</guid>
      <description><![CDATA[There's no question that executives have had their hands full navigating the rocky economic environment of the past year. Although we at Morningstar prefer a quality business over topnotch management--as it is much easier for a company to change management teams than industries--recent events have brought home the point that management decisions can have a dramatic effect on a company's fate.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553730>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 14:30:12 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FAST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">O</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SRCL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STRA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SYY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553730</link>
    </item>
    <item>
      <title>US Stock Futures Retreat After Goldman Sachs Earnings, Citigroup (NYSE: C) Eyed</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553571</guid>
      <description><![CDATA[US stock futures declined on Thursday after Citigroup and Goldman Sachs Group reported third-quarter results.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553571>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 12:59:28 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">C</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IBM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XLNX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553571</link>
    </item>
    <item>
      <title>Tickers For The Latest Portfolio Reshaping</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3459489</guid>
      <description><![CDATA[Fortunately my portfolio management methods don’t revolve around&#160; frequent trading.&#160; One of my kids came up to me recently and said, “What did you do today, Dad?”&#160; I said, “I made one trade, and I did a bunch of research.”&#160; He then asked, “How often do you trade?”&#160; I answered, “That was my first trade in a week, and I haven’t traded much in the last two months, but that’s not normal.&#160; There is no normal for me. When the market is really volatile, I trade a lot more, selling when stocks are rising, and buying when they are selling off.&#160; When the market is relatively placid, I don’t do much.” He looked at me, kind of smiled, and moved on.&#160; Information overload from Dad.



Most people and investment managers trade too often.&#160; They sell their winners too rapidly, and panic too soon on their losers.&#160; Now, I’m not advocating “buy and forget,” or Buffett’s statement, “Our favorite holding period is forever.”<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3459489>[More...]</a>]]></description>
      <pubDate>Fri, 04 Sep 2009 15:45:21 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACGL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AEE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AEP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AHL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">APA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">APC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ATI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AWH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BHP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BOBE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CPWR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CTAS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DUK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ECA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EFX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EIX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ELNK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EME</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ENH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EXC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FIC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FISV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HELE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HON</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HSC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IVC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MGEE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MUR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NJR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NPK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NTRI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OCR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OGE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PCG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PCP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PDCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RLI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SJM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNPS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SWY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TFX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TLM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TOT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TYC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UGI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VAR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VOD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WEC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WGL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XEL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ZMH</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3459489</link>
    </item>
    <item>
      <title>CSL Ltd. (ASX:CSL): First To Begin Swine Flu Vaccine Trial</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3364955</guid>
      <description><![CDATA[CSL Limited (ASX:CSL) (PINK:CMXHY) is expected to begin the first human trials for a swine influenza (flu) vaccine on 7/22/09 in Australia. The seven-week trial will inject healthy volunteers age 18-64 as deaths, infections, and media coverage of the H1N1 virus gain momentum across the globe. The seven-week study will be closely monitored to measure the immune responses of the subjects in order to determine the optimal antigen (the substance which elicits an immune response and thus protection f (...)<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3364955>[More...]</a>]]></description>
      <pubDate>Wed, 22 Jul 2009 17:28:36 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ASX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMXHY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CSL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HEB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3364955</link>
    </item>
    <item>
      <title>Report: Women still underrepresented in key positions at Chicago companies: Census from the Chicago Network shows number of female directors declined</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3648148</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Nov. 18--Women in Chicago remain underrepresented in the top-ranking positions at Chicago's 50 largest public companies, according to the 12th annual Chicago Census from the Chicago Network, the women's professional organization that tracks the representation of women in key leadership positions. &lt;/li&gt;&lt;li&gt;However, the report found, the number of companies with no female directors (seven) and no female executive officers (17) increased by one in each category. &lt;/li&gt;&lt;li&gt;&quot;Best performers&quot; in terms of women represented as board members or executive officers were Discover Financial Services, Jones Lang LaSalle Inc., Kraft Foods Inc., Sara Lee Corp., Baxter International Inc., CME Group Inc., Corn Products International Inc., Exelon Corp., Hewitt Associates Inc., Northern Trust Corp., Allstate Corp. and Sears Holdings Corp.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3648148>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 21:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CME</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CPO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DFS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EXC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HEW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JLL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LKQX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NTRS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SHLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SHS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">USM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3648148</link>
    </item>
    <item>
      <title>Baxter's Earnings Jump 12 Percent on Strong Bioscience Sales</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3557167</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 16--Baxter International Inc. reported Thursday that third-quarter  profit rose 12 percent, thanks to sales of bioscience products such as its  blood-clotting drug Advate. &lt;/li&gt;&lt;li&gt;The Deerfield-based medical-product giant said net income grew to $530  million, or 87 cents a share, compared with $472 million, or 74 cents, in the  year-earlier quarter. &lt;/li&gt;&lt;li&gt;Excluding special items, Baxter recorded earnings of 98 cents per share,  above its guidance for the quarter.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3557167>[More...]</a>]]></description>
      <pubDate>Fri, 16 Oct 2009 16:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3557167</link>
    </item>
    <item>
      <title>Baxter Adjusted Profit Tops Estimates, but Currency Exchange Hits Sales; Company Lifts Outlook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3555009</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Oct. 15--Baxter International Inc. reported third-quarter profits up 12 percent thanks to sales of bioscience products like its blood clotting drug Advate. &lt;/li&gt;&lt;li&gt;Sales were flat at $3.14 billion, compared to $3.15 billion in the year-ago quarter thanks to the negative impact of foreign exchange. &lt;/li&gt;&lt;li&gt;The report beat analysts estimates by about two cents a share.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3555009>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 18:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3555009</link>
    </item>
    <item>
      <title>Baxter International 3Q profit rises 12 percent</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553644</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Specialty drug and medical device maker Baxter International Inc. said Thursday its profit grew 12 percent in the third quarter despite unfavorable currency exchange rates that held back its sales.&lt;/li&gt;&lt;li&gt;Its profit grew to $530 million, or 87 cents per share, from $472 million, or 74 cents per share, a year ago.&lt;/li&gt;&lt;li&gt;Excluding the items, profit grew to 98 cents per share from 88 cents per share, a penny above Wall Street expectations.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553644>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 13:47:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553644</link>
    </item>
    <item>
      <title>Baxter International 3Q profit rises 12 percent</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553512</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Specialty drug and medical device maker Baxter International Inc. says its profit grew 12 percent in the second quarter despite unfavorable currency exchange rates that held back its sales.&lt;/li&gt;&lt;li&gt;Excluding one-time charges, profit grew to 98 cents per share from 88 cents per share, a penny above Wall Street expectations.&lt;/li&gt;&lt;li&gt;Revenue was roughly unchanged at $3.15 billion, while analysts expected $3.19 billion.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553512>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553512</link>
    </item>
    <item>
      <title>Skin hydration product unveiled by Baxter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3538581</guid>
      <description><![CDATA[Skin hydration product unveiled by Baxter<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3538581>[More...]</a>]]></description>
      <pubDate>Thu, 08 Oct 2009 17:32:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3538581</link>
    </item>
    <item>
      <title>Talecris Biotherapeutics delayed IPO set to debut</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3514033</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;NEW YORK - Talecris Biotherapeutics Inc. is expected to go public this week after a two-year pause, potentially giving the two private equity firms behind the biotechnology company a payday while allowing Talecris to pay debt.&lt;/li&gt;&lt;li&gt;The Research Triangle Park, N.C.-based maker of protein therapies is offering 28.9 million shares for $18 to $20 apiece, while stockholders are offering 15.8 million shares, according to a Securities and Exchange Commission filing. &lt;/li&gt;&lt;li&gt;The company said it would use about $515 million in proceeds to pay loans, and shareholders Cerberus Capital Management and Ampersand Ventures will raise $300 million by selling their own stock.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3514033>[More...]</a>]]></description>
      <pubDate>Tue, 29 Sep 2009 18:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3514033</link>
    </item>
    <item>
      <title>Cook Fears Taxes Will Hurt Industry</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3506386</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 24--Cook Medical, one of Indiana's largest and fastest-growing  technology companies, is protesting a U.S. Senate proposal that would add  billions of dollars in new taxes on the medical-device industry to help pay  for health-care reform. &lt;/li&gt;&lt;li&gt;The Bloomington company, which makes a wide assortment of stents,  needles, catheters and other devices used in hospitals around the world,  warned Wednesday that extra taxes would slow job growth and divert huge  amounts of money that otherwise could be invested in new life-saving products. &lt;/li&gt;&lt;li&gt;This is an industry that we  dominate worldwide,&quot; Kem Hawkins, Cook Medical's president, said in an  interview.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3506386>[More...]</a>]]></description>
      <pubDate>Thu, 24 Sep 2009 16:49:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3506386</link>
    </item>
    <item>
      <title>Wilkowski, Bell Cruise to Easy Wins</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3486538</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Sep. 16--Toledo voters turned out in low numbers yesterday to select lawyer Keith Wilkowski and retired fire chief Mike Bell to run against each other for mayor on Nov. 3 to replace retiring Democratic Mayor Carty Finkbeiner. &lt;/li&gt;&lt;li&gt;Mr. Wilkowski, 53, a Democrat, is expected to get that party's endorsement. &lt;/li&gt;&lt;li&gt;&quot;I feel very good about how the campaign has gone,&quot; Mr. Wilkowski said after joining supporters at Michael's Bar &amp; Grill downtown to watch the vote totals arrive.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3486538>[More...]</a>]]></description>
      <pubDate>Thu, 17 Sep 2009 01:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3486538</link>
    </item>
    <item>
      <title>Stocks Finish Higher</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3356118</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;U.S. stocks closed higher Thursday as price drops earlier in the session led to late bargain hunting. &lt;/li&gt;&lt;li&gt;The firming in the market followed news of a 2-point rise in the National Association of Home Builders' housing market index. &lt;/li&gt;&lt;li&gt;Investors weighed a jump in second-quarter profits at JPMorgan Chase, disappointing results from Nokia (NOK), and a possible CIT Group bankruptcy.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3356118>[More...]</a>]]></description>
      <pubDate>Fri, 17 Jul 2009 14:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CIT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EWBC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GOOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HOG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IBM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MAR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NOK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3356118</link>
    </item>
    <item>
      <title>Baxter Raises Quarterly Dividend</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3622221</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;The Board of Directors of Baxter International Inc. (NYSE:BAX) today   declared a quarterly dividend of $0.29 per Baxter common share. &lt;/li&gt;&lt;li&gt;Baxter International Inc., through its subsidiaries, develops,   manufactures and markets products that save and sustain the lives of   people with hemophilia, immune disorders, infectious diseases, kidney   disease, trauma, and other chronic and acute medical conditions. &lt;/li&gt;&lt;li&gt;As a   global, diversified healthcare company, Baxter applies a unique   combination of expertise in medical devices, pharmaceuticals and   biotechnology to create products that advance patient care worldwide.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3622221>[More...]</a>]]></description>
      <pubDate>Tue, 10 Nov 2009 13:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3622221</link>
    </item>
    <item>
      <title>Baxter Reports Double-Digit EPS Growth for Third Quarter 2009</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3553521</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Baxter International Inc. (NYSE:BAX) today reported solid financial   results for the third quarter of 2009, and provided its fourth quarter   and updated full-year 2009 financial outlook.&lt;/li&gt;&lt;li&gt;The third quarter results include after-tax special charges   totaling $69 million (or $0.11 per diluted share) primarily for fixed   asset write-offs related to the discontinuation of the company's SOLOMIX   drug delivery system in development, and planned retirement costs   associated with the SYNDEO PCA Syringe Pump. &lt;/li&gt;&lt;li&gt;This financial performance was the result of continued margin   expansion, expense leverage and benefits derived from the company's   ongoing share repurchase program.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3553521>[More...]</a>]]></description>
      <pubDate>Thu, 15 Oct 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3553521</link>
    </item>
    <item>
      <title>Baxter Named to Dow Jones Sustainability Index for 11th Consecutive Year</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3457317</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Baxter International Inc. (NYSE: BAX) announced today that it has been   named 2009 Medical Products Industry Leader of the Dow Jones   Sustainability World Index (DJSI World) and the Dow Jones Sustainability   North America Index (DJSI North America). &lt;/li&gt;&lt;li&gt;This marks the 11th   consecutive year that the company has been listed in the DJSI and the   eighth year the company has been named Medical Products Industry Leader   since the launch of the DJSI in 1999.&lt;/li&gt;&lt;li&gt;&quot;Our focus on sustainability reflects our values, enhances our business   and is part of our responsibility as a global leader,&quot; said Robert L.   Parkinson, Jr., Baxter's chairman and chief executive officer.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3457317>[More...]</a>]]></description>
      <pubDate>Thu, 03 Sep 2009 21:09:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3457317</link>
    </item>
    <item>
      <title>Laureate Pharma Elects New Board Member ; - Joel A. Tune Enhances Organization, Providing Leadership and Strategic Direction -</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3420719</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;PRINCETON, N.J., Aug. 18 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the Election of Joel A. Tune as a new member of its Board of Directors. &lt;/li&gt;&lt;li&gt;Along with providing expert guidance and strategic direction focused on Laureate's contract manufacturing business, Mr. Tune brings to Laureate more than 20 years of experience in P&amp;L, strategy, operations, marketing and engineering leadership, in rapid- growth and transitional health products and service businesses. &lt;/li&gt;&lt;li&gt;&quot;Joel's exceptional mix of contract manufacturing expertise, in- depth knowledge of customer needs, and strong leadership skills will enable us to propel Laureate's growth and development and to achieve worldwide recognition for our fully-integrated contract development and bioprocessing services,&quot; said Robert J. Broeze, Ph.D., President &amp; Chief Executive Officer of Laureate.&quot;&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3420719>[More...]</a>]]></description>
      <pubDate>Tue, 18 Aug 2009 13:57:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3420719</link>
    </item>
    <item>
      <title>StockPreacher.com Issues Trading Outlook for Nabi Biopharmaceuticals</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3417281</guid>
      <description><![CDATA[StockPreacher.com announces an investment report featuring Nabi Biopharmaceuticals . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3417281>[More...]</a>]]></description>
      <pubDate>Thu, 13 Aug 2009 12:38:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NABI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3417281</link>
    </item>
    <item>
      <title>StockPreacher.Com Issues Trading Outlook for Keryx Biopharmaceuticals Inc.</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3403926</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;DALLAS, Aug. 10, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring pharmaceutical company Keryx Biopharmaceuticals Inc. (Nasdaq:KERX). &lt;/li&gt;&lt;li&gt;The investment report on Keryx Biopharmaceuticals Inc. (Nasdaq:KERX) should be of particular interest to other pharmaceutical companies: Baxter International Inc. (NYSE:BAX), Amgen Inc. (Nasdaq:AMGN), Genzyme Corp. (Nasdaq:GENZ) and Amicus Therapeutics Inc. (Nasdaq:FOLD).&lt;/li&gt;&lt;li&gt;It is available at: http://www.stockpreacher.com/n/KERX&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3403926>[More...]</a>]]></description>
      <pubDate>Mon, 10 Aug 2009 11:46:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FOLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KERX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3403926</link>
    </item>
    <item>
      <title>Baxter Completes Production of First Commercial Batches of A/H1N1 Pandemic Vaccine</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3396547</guid>
      <description><![CDATA[Baxter International Inc. (NYSE: BAX) today announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations. CELVAPAN, the brand name for the company’s A/H1N1 pandemic influenza vaccine, is made using Baxter’s proprietary Vero cell culture technology.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3396547>[More...]</a>]]></description>
      <pubDate>Wed, 05 Aug 2009 20:45:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3396547</link>
    </item>
    <item>
      <title>Baxter Declares Quarterly Dividend and Announces New Share Repurchase Authorization</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3375303</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;The Board of Directors of Baxter International Inc. (NYSE:BAX) today   declared a quarterly dividend of $0.26 per share of Baxter common stock.   &lt;/li&gt;&lt;li&gt;The Board of Directors also authorized the repurchase of an additional   $2 billion of the company's common stock, which is expected to be   executed upon completion of the company's existing share repurchase   program. &lt;/li&gt;&lt;li&gt;&quot;The continuation of our share repurchase program   reflects our confidence in achieving longer-term objectives while   investing in R&amp;D and new business development opportunities.&quot;&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3375303>[More...]</a>]]></description>
      <pubDate>Tue, 28 Jul 2009 14:03:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3375303</link>
    </item>
    <item>
      <title>Baxter Reports Strong Second Quarter 2009 Financial Results and Raises Full-Year Outlook</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3353030</guid>
      <description><![CDATA[&lt;ul&gt;&lt;li&gt;Baxter International Inc. (NYSE:BAX) today reported strong financial   results for the second quarter of 2009 and raised its full-year   financial outlook.&lt;/li&gt;&lt;li&gt;This performance was the result of strong underlying fundamentals   across the portfolio, improved margins, and benefits derived from the   company's ongoing share repurchase program.&lt;/li&gt;&lt;li&gt;Contributing to these results was growth across multiple   product categories including products used in peritoneal dialysis (PD)   treatment, intravenous therapies, anesthesia products and injectable   drugs.&lt;/li&gt;&lt;ul&gt;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3353030>[More...]</a>]]></description>
      <pubDate>Thu, 16 Jul 2009 11:48:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3353030</link>
    </item>
    <item>
      <title>Baxter and Halozyme Announce Completion of Patient Enrollment in Phase III Pivotal Trial of GAMMAGARD LIQUID™ with rHuPH20 Enzyme</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3350898</guid>
      <description><![CDATA[Baxter International Inc. (NYSE:BAX) and Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced completion of patient enrollment in the Phase III pivotal study of GAMMAGARD LIQUID [Immune Globulin Intravenous (Human) 10%] (also known as KIOVIG outside of the United States) with rHuPH20 (recombinant human hyaluronidase enzyme) for the treatment of primary immunodeficiency disorder (PID). Patients will receive monthly subcutaneous (SC) injections of Halozyme’s rHuPH20 with Baxter’s GAMMAGARD LIQUID.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3350898>[More...]</a>]]></description>
      <pubDate>Wed, 15 Jul 2009 13:13:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HALO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3350898</link>
    </item>
    <item>
      <title>Form  4          BAXTER INTERNATIONAL      For: Dec 02  Filed by: RIEDEL NORBERT G (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3689365</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3689365>[More...]</a>]]></description>
      <pubDate>Fri, 04 Dec 2009 21:31:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3689365</link>
    </item>
    <item>
      <title>Form  4          BAXTER INTERNATIONAL      For: Nov 09  Filed by: GATLING JAMES M (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3631520</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3631520>[More...]</a>]]></description>
      <pubDate>Thu, 12 Nov 2009 21:20:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3631520</link>
    </item>
    <item>
      <title>Form  4          BAXTER INTERNATIONAL      For: Oct 21  Filed by: GAVIN JAMES R III (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3576460</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3576460>[More...]</a>]]></description>
      <pubDate>Fri, 23 Oct 2009 22:24:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3576460</link>
    </item>
    <item>
      <title>Form  3/A        Scharf David P.           For: Sep 01 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3475182</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3475182>[More...]</a>]]></description>
      <pubDate>Fri, 11 Sep 2009 22:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3475182</link>
    </item>
    <item>
      <title>Form  3          Scharf David P.           For: Sep 01 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3465306</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3465306>[More...]</a>]]></description>
      <pubDate>Tue, 08 Sep 2009 22:44:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3465306</link>
    </item>
    <item>
      <title>Form  4          GAVIN JAMES R III         For: Jul 16 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3356844</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3356844>[More...]</a>]]></description>
      <pubDate>Fri, 17 Jul 2009 22:31:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3356844</link>
    </item>
    <item>
      <title>Form  4          Terrell Karenann K        For: May 11 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3229424</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3229424>[More...]</a>]]></description>
      <pubDate>Tue, 12 May 2009 23:02:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3229424</link>
    </item>
    <item>
      <title>Form  4          Baughman Michael J        For: May 11 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3229418</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3229418>[More...]</a>]]></description>
      <pubDate>Tue, 12 May 2009 23:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3229418</link>
    </item>
    <item>
      <title>Form  4          GATLING JAMES M           For: May 11 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3229422</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3229422>[More...]</a>]]></description>
      <pubDate>Tue, 12 May 2009 23:01:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3229422</link>
    </item>
    <item>
      <title>Form  4          STALLKAMP THOMAS T        For: May 05 (10K)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3223390</guid>
      <description><![CDATA[<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3223390>[More...]</a>]]></description>
      <pubDate>Thu, 07 May 2009 23:17:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3223390</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/customsymbolfeed.aspx?symbols=BAX" rel="self" type="application/rss+xml" />
  </channel>
</rss>